Cardiac Marker Analyzer Market Will Generate Massive Revenue in Coming Years : Roche, Beckman Coulter, Siemens Healthineers
The global Cardiac Marker Analyzer market is predicted to reach US$ 4.75 Billion by 2027. Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results...
View full press release